CRISPR is now a household term. Stories of genome editing therapies like Casgevy and Baby KJ have been headlines in our inboxes for years. Despite those cases, and the optimism they bring, genome editing has had significant challenges moving into the clinic.

This GEN Live show brings together a panel of leading experts to break down the latest advances, innovations, and challenges shaping genome editing. The discussion covers a lot of bases: CRISPR breakthroughs, emerging gene editing platforms, clinical trial milestones, regulatory shifts, access, off-target effects and safety considerations, and the growing role of large-scale population genomics in guiding precision therapies. Watch the event to learn more from our expert panelists and hear the questions submitted by our audience during the discussion.

Produced with support from: